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Vertebrate Hedgehog (Hh) signaling is initiated at
primary cilia by the ligand-triggered accumulation
of Smoothened (Smo) in the ciliary membrane. The
underlying biochemical mechanisms remain un-
known. We find that Hh agonists promote the associ-
ation between Smo and Evc2, a ciliary protein that is
defective in two human ciliopathies. The formation of
the Smo-Evc2 complex is under strict spatial control,
being restricted to a distinct ciliary compartment, the
EvC zone. Mutant Evc2 proteins that localize in cilia
but are displaced from the EvC zone are dominant
inhibitors of Hh signaling. Disabling Evc2 function
blocks Hh signaling at a specific step between Smo
and the downstream regulators protein kinase A
and Suppressor of Fused, preventing activation of
the Gli transcription factors. Our data suggest that
the Smo-Evc2 signaling complex at the EvC zone is
required for Hh signal transmission and elucidate
the molecular basis of two human ciliopathies.
INTRODUCTION
Primary cilia have emerged as important signaling centers during
development (Goetz and Anderson, 2010). A number of human
genetic diseases, called ciliopathies, are caused by defects in
cilia structure or function. Patients suffering from these syn-
dromes display pleiotropic phenotypes that affect many organ
systems, highlighting the ubiquity of cilia and their profound
role in human physiology (Novarino et al., 2011). Although a
considerable body of work has focused on the phenotypic
consequences of defects in cilia and on the localization of
signaling proteins in cilia, the biochemical mechanisms that drive
signal transduction at cilia remain poorly understood.
The Hedgehog (Hh) signaling pathway is orchestrated at
primary cilia, and many of the phenotypes seen in patients with
ciliopathies can be attributed to defective Hh signaling (Huangfu
et al., 2003; Goetz and Anderson, 2010). Proper Hh signal trans-
duction critically depends on a set of protein trafficking events at
cilia (Corbit et al., 2005; Haycraft et al., 2005; Rohatgi et al., 2007;
Kim et al., 2009). When an Hh ligand, such as Sonic Hedgehog
(Shh), is received by the cell, the 7-pass transmembrane (TM)
protein Smoothened (Smo) accumulates to high levels in the
ciliary membrane (Corbit et al., 2005). The mechanism by whichDevelopmSmo concentration in cilia ultimately leads to activation of the Gli
family of transcription factors is one of the unsolved mysteries in
the vertebrate Hh pathway. Smo has to overcome the two nega-
tive regulators of the Gli proteins, Suppressor of Fused (SuFu)
and protein kinase A (PKA). Smo signaling promotes the trans-
port of Gli and SuFu to the tip of the cilium, allowing Glis to disso-
ciate from SuFu and enter the nucleus to transcribe target genes
(Kim et al., 2009; Humke et al., 2010; Tukachinsky et al., 2010).
Despite the genetic and cell-biological evidence linking the Hh
pathway to primary cilia, surprisingly few protein interactions or
enzymatic links between ciliopathy proteins and core compo-
nents of the Hh pathway have been described. An obstacle to
dissecting Hh biochemistry at cilia is presented by the fact that
many defects seen in ciliopathies compromise the structural
integrity of cilia, making it difficult to disentangle direct from indi-
rect effects.
Among the ciliopathies that lead to defects in Hh signaling
(Goetz and Anderson, 2010), Ellis–van Creveld syndrome (EvC;
MIM 225500) and Weyers Acrofacial Dysostosis (Weyers; MIM
193530) are two related inherited disorders that are uniquely
characterized by ultrastructurally normal cilia (Ruiz-Perez et al.,
2000, 2003; Galdzicka et al., 2002; Takeda et al., 2002; Blair
et al., 2011). Mutations in the EVC2 gene can cause both EvC
and Weyers and have been shown to impair Hh signaling in
cardiac, skeletal, and orofacial tissues during development
(Ruiz-Perez and Goodship, 2009; Blair et al., 2011). However,
questions regarding the mechanism of Evc2’s function in Hh
signaling, and the crucial issue of whether the effect of Evc2 is
direct or indirect, have remained unresolved.
We find a direct role for Evc2 in the signaling step that trans-
lates Smo activation to the inhibition of SuFu and PKA. The ciliary
accumulation of Smo in response to Hh signaling leads to the
physical association of Evc2withSmoat a spatially distinct ciliary
compartment named the EvC zone. The biochemical patho-
physiology of EvC and Weyers syndromes is explained by the
failure of this signaling complex to assemble at the EvC zone.RESULTS
Function and Subcellular Localization of Evc2 in
Fibroblasts
Although patients with EvC and Weyers have a similar constella-
tion of congenital anomalies, EvC is a recessive disorder and
Weyers is a dominant disorder (Ruiz-Perez and Goodship,
2009). EvC is caused by loss-of-function mutations in both
alleles of either EVC2 or a second gene called EVC (Ruiz-Perez
and Goodship, 2009). These genes encode two single-passental Cell 23, 823–835, October 16, 2012 ª2012 Elsevier Inc. 823
Figure 1. Evc2 Is a Positive Regulator of Hh Signaling Localized at the EvC Zone in Primary Cilia
(A) Gli1 induction was used to measure Shh-triggered signaling in NIH/3T3 cells transfected with a nontargeting (NT) siRNA or siRNAs targeting Evc2 and Smo.
(B) The differentiation of C3H10T1/2 cells into osteoblasts was assayed by the increase in alkaline phosphatase activity (mean ± SD) after treatment with the Smo
agonist SAG (36 hr). Depletion of Evc2 in this experiment is shown in Figure S1A.
(C) Schematic of the Evc2- and Evc2DW-YFP-FLAG proteins used to make stable cell lines. Evc2DW lacks the W-peptide (blue) at the C terminus.
(D) Evc2-YFP and Evc2DW-YFP were expressed at similar levels in stable cell lines (top, anti-YFP blot), and Evc2-YFP and endogenous Evc2 were present at
similar levels (bottom, anti-Evc2 blot). Anti-Evc2 recognized Evc2DW-YFP poorly.
(E) SAG (12 hr) induced Gli1 protein in Evc2-YFP cells but not in Evc2DW-YFP cells.
(F) Localization of endogenous Evc2 (anti-Evc2, green) at cilia (red) marked by anti-acetylated tubulin (acTub) in NIH/3T3 cells.
(G) Mean (± 95% confidence interval [CI], n = 24) Evc2 fluorescence at cilia from such images.
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each other (Blair et al., 2011). The small interfering RNA
(siRNA)-mediated depletion of Evc2 from either NIH/3T3 fibro-
blasts or C3H10T1/2 multipotent mesenchymal cells inhibited
the Shh-triggered induction ofGLI1, a direct Hh target gene (Fig-
ure 1A; Figure S1A available online). Evc2 depletion also blocked
the Hh-induced differentiation of C3H10T1/2 cell into osteo-
blasts (Figure 1B). Three controls rigorously established the
specificity of the Evc2 siRNA (Figures S1B–S1E).
In contrast to EvC, Weyers is a dominant syndrome caused by
specific mutations that delete the last 43 amino acids (aa) at
the C terminus of Evc2, generating a dominant-negative protein
that can inhibit Hh signaling (Valencia et al., 2009). Hereafter, we
refer to this truncated protein as Evc2DW, and to the missing
fragment in the protein as the Weyers peptide (W-peptide). We
constructed two stable NIH/3T3 cell lines expressing full-length
Evc2 or Evc2DW, each tagged with a YFP-FLAG tag (Figure 1C).
Evc2-YFP, Evc2DW-YFP, and endogenous Evc2 were all ex-
pressed at equivalent levels in these cells (Figure 1D).
As predicted by the genetics of Weyers syndrome, the ex-
pression of Evc2DWproduced a near-total block of Hh signaling
stimulated by the direct Smo agonist SAG (Figure 1E). To ensure
that the large YFP-FLAG tag did not alter function, we
confirmed the effect of Evc2DW in stable cell lines expressing
Evc2 or Evc2DW taggedwith a single FLAG epitope (Figure S1F).
Given their identical behavior, we hereafter refer to both sets
of stable cell lines as Evc2 and Evc2DW cells. Taken together,
both siRNA-based loss-of-function and dominant-negative ex-
pression confirm the critical role of Evc2 in Hh signaling and
establish the Evc2DW cell line as a relevant model for dissecting
the mechanistic role of Evc2.
Importantly, neither the frequency of ciliation nor the length
distribution of cilia was affected when Evc2 was disabled by
siRNA transfection or Evc2DW expression (Figures S1G–S1J).
In addition, three proteins commonly used to label cilia—IFT88,
Arl13b, and Inv (Pazour et al., 2000;Watanabe et al., 2003; Casp-
ary et al., 2007)—all showed normal ciliary localization in
Evc2DW cells (Figures S1K–S1M). The lack of a general require-
ment for Evc2 in cilia structure and function, along with the
strong effects of Evc2 on Hh signaling, provided a unique oppor-
tunity to understand how a ciliopathy protein can regulate Hh
signaling in the context of otherwise normal cilia.
EvC and Weyers syndromes have been classified as ciliopa-
thies on the basis of a report that both Evc2 and Evc localize
to basal bodies of primary cilia (Blair et al., 2011). Both endoge-
nous Evc2 (Figures 1F and 1G) and stably expressed Evc2-YFP
(Figure 1H) localized in a punctum near the base of the ciliary
axoneme regardless of Hh pathway activity (Figure 1J). We
defined the subciliary localization of Evc2-YFP relative to a series
of markers for known ciliary compartments. In contrast to the
previous reports, Evc2 was not localized at the basal body (Fig-
ure 1H), and instead was found just distal to the transition zone
(TZ). The TZ was recently shown to form a barrier between the(H) Localization of stably expressed Evc2-YFP (anti-YFP, green) relative to marke
fluorescent intensities for each of the channels along the cilium from base (left) t
(I) Images of Evc2 localization captured by STED microscopy. (J) Localization of
SAG (2 hr). Scale bars: 2.5 mm and 0.5 mm.
See also Figure S1.
Developmciliary membrane and the plasma membrane (Craige et al.,
2010; Chih et al., 2012; Garcia-Gonzalo et al., 2011; Williams
et al., 2011). Analogously to some TZ proteins, Evc2 formed
a ring-like collar around the cilium (Figure 1I). Evc, the second
protein that is mutated in EvC syndrome, precisely colocalized
with Evc2, consistent with the observation that these proteins
form a complex (Figure 1J) (Blair et al., 2011).
In summary, Evc and Evc2 can traverse the TZ barrier and are
colocalized in a narrow region, hereafter called the EvC zone,
that sits between the TZ and the Inv compartment. This compart-
ment is likely a general feature of primary cilia, since endogenous
Evc and Evc2 display a similar localization pattern at the cilia
base in both epithelial and mesenchymal cell lines and primary
tissues (Figures S1N–S1P).
Identification of the Step in Hedgehog Signaling that
Requires Evc2
Heretofore, the step in Hh signaling that is impaired in EvC and
Weyers was unknown. We found that the expression of Evc2DW
did not affect the levels of endogenous Evc2 or several key Hh
pathway proteins (Figure S2A). We tested the requirement for
Evc2 when Hh signaling was activated at different levels in the
pathway. Evc2 and Evc2DW cells were treated with Shh, which
activates the pathway at the level of Ptc1, or with SAG or 20-hy-
droxycholesterol, both of which activate Smo (Chen et al., 2002;
Nachtergaele et al., 2012). In all three cases, Evc2DW blocked
signaling (Figure 2A and Figures S2B and S2C). Strikingly,
Evc2 was also required for Hh signaling initiated by a constitu-
tively active oncogenic mutant of Smo, SmoM2 (Figure 2B) (Xie
et al., 1998).
Although the precise signaling events downstream of Smo
remain poorly understood, it is known that they depend on the
negative regulators PKA andSuFu. PKA is a powerful suppressor
of Hh signaling, and blockage of PKA activity is sufficient to fully
activate Hh target gene transcription even in the absence of Shh
(Lepage et al., 1995; Hammerschmidt et al., 1996; Tuson et al.,
2011). Expression of dominant-negative PKA (dnPKA) induced
Hh target gene transcription to equal degrees in both Evc2 and
Evc2DW cells (Figure 2C). Mouse embryonic fibroblasts (MEFs)
lacking SuFu (sufu/ cells) also showed high levels of Hh target
gene transcription consistent with activated signaling (Sva¨rd
et al., 2006). Hh reporter gene activity in sufu/ cells was unaf-
fected by the expression of either Evc2 or Evc2DW, and reintro-
duction of SuFu to these cells restored sensitivity to Evc2DW
(Figure 2D). Finally, Evc2DW did not inhibit Hh reporter activity
that was directly stimulated by coexpression of the three Hh tran-
scription factors, Gli1, Gli2, and Gli3 (Figure 2E).
Smo activation regulates the Gli transcription factors in two
distinct ways. When the Hh signal is received, Gli3R production
is turned off, and instead Gli2FL and Gli3FL are converted to
transcriptional activator proteins (GliA) that translocate into the
nucleus to activate target genes. In the absence of signaling,
both Evc2 and Evc2DW cells had equal amounts of Gli3R inrs of various ciliary compartments. Plots below the images indicate normalized
o tip (right).
Evc2-YFP (green) and endogenous Evc (red) at cilia (white) in cells exposed to
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Figure 2. Evc2 Is Required for Hh Signaling
at a Step between Smo and PKA
(A) Hh reporter activity in response to SAG, Shh, or
20-OHC (10 mM) in cells stably expressing Evc2 or
Evc2DW. Effects on the induction of endogenous
Gli1 are shown in Figure S2B.
(B and C) Hh reporter activity measured in Evc2 or
Evc2DW cells transiently transfected with consti-
tutively active SmoM2 (B) or dnPKA (C).
(D) Effect of Evc2DW on Hh signaling (36 hr) in
sufu/ MEFs or sufu/ MEFs rescued by the
stable expression of SuFu.
(E) Hh reporter activity measured in Evc2 or
Evc2DW cells transiently transfected with the in-
dicated Gli constructs.
(F and G) Levels of full-length (Gli3FL) and
repressor (Gli3R) forms of Gli3 (F) or full-length Gli2
(G) in the nucleus of Evc2 and Evc2DW cells left
untreated or treated with SAG. The number below
each lane in (F) denotes the Gli3FL/R ratio, and the
bar below each lane denotes the relative fraction of
Gli2/3 in the nucleus [N] and the cytoplasm [C].
(H) Evc2 functions at the level of Smo or at a
step between Smo and SuFu/PKA. Positive and
negative regulators are colored in green and red,
respectively. For (A)–(E), themean values (± SD) are
plotted.
See also Figure S2.
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of Gli3FL to Gli3R (Figure 2F). However, Hh signaling was unable
to extinguish Gli3R production in Evc2DW cells (Figure 2F).
In addition, all aspects of SAG-induced GliA formation were
blocked in Evc2DW cells. Gli3FL failed to dissociate from SuFu
(Figure S2F), and both Gli3FL and Gli2FL proteins failed to trans-
locate from the cytoplasm to the nucleus (Figures 2F and 2G;
Figures S2D and S2E).
To summarize the above epistasis analysis, Evc2 is required in
the Hh signaling pathway at the level of or immediately down-
stream of Smo but upstream of PKA and SuFu (Figure 2H).
Evc2 may be required for Smo to adopt its fully active conforma-
tion in cilia, or it may relay the signal from Smo to downstream
steps in signaling.826 Developmental Cell 23, 823–835, October 16, 2012 ª2012 Elsevier Inc.The Role of Evc2 in Trafficking Hh
Pathway Proteins to Primary Cilia
Given that Evc2 is critical for all aspects of
Smo signaling, we expected it to play
a role in the trafficking of Smo to primary
cilia. Surprisingly, we found that Smo
accumulated in cilia normally in response
to SAG in both Evc2 and Evc2DW cells
and in NIH/3T3 cells depleted of endoge-
nous Evc2 by siRNA (Figures 3A and 3B;
Figures S3A and S3B). Smo activation
and accumulation in cilia are correlated
with an increase in the levels of Gli2,
Gli3, and SuFu at the tips of cilia, a step
that is thought be critical for the nuclear
translocation of the Gli proteins (Kim
et al., 2009; Tukachinsky et al., 2010).
SAG-induced recruitment of endogenousGli2, Gli3, and SuFu to the tips of cilia was blunted in Evc2DW
cells and in cells depleted of Evc2 by siRNA (Figures 3C–3H;
Figures S3C–S3E). Thus, Evc2 is required to relay Smo activation
to the recruitment of SuFu and Gli proteins to the tips of primary
cilia.
A Localization Signal for the EvC Zone
To shed light on the mechanism of Evc2 function, we focused on
Evc2DW, a dominant inhibitor of Hh signaling. Because Evc2DW
was inserted into the membrane appropriately and transported
along the secretory pathway normally (Figures S4A–S4C), we
asked whether it localized in cilia like the wild-type (WT) pro-
tein. Evc2DW-YFP was efficiently targeted to cilia; however, its
pattern of localization within the cilium was markedly different
Figure 3. Evc2 Is Required for the Accumulation of Gli2, Gli3, and SuFu in Cilia
Confocal images show levels of endogenous Smo (A), Gli2 (C), Gli3 (E), and SuFu (G) (all white) at representative cilia (red) from Evc2 and Evc2DW cells left
untreated or treated with SAG. Multiple cilia from such images were used to quantitate the mean (± 95%CI) fluorescence of Smo (n = 49) (B), Gli2 (n = 25) (D), Gli3
(n = 22) (F), and SuFu (n = 22) (H) at cilia. Treatment times were 4 hr for (B), (D), and (F), and 12 hr for (H). Statistical test: one-way ANOVA with Tukey posttest;
p < 0.001 (***) and p > 0.05 (ns). Scale bars: 2.5 mm.
See also Figure S3.
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tum at the EvC zone, Evc2DW-YFP was distributed along the
entire length of the ciliary membrane (Figures 4A–4C).
The ability of Evc2DW to potently block Hh signaling pro-
vided a facile assay to uncover important sequence elements
within the W-peptide. Using a combination of deletion analysis,
alanine-scanning mutagenesis, and directed mutagenesis, we
identified two contiguous residues within the W-peptide (F1185
and V1186) that have strong effects on the dominant-negative
phenotype (Figures 4D–4G). Alanine (Ala) mutants overlapping
these residues, but not several other Ala mutants of the
W-peptide, blocked Hh signaling (Figures 4F and 4G; Figures
S4D and S4E), demonstrating the selective importance of this
FV motif.
Given that the W-peptide was required for EvC zone localiza-
tion, we tested whether it could target a different ciliary mem-
brane protein to this compartment. YFP-tagged Smo (YFP-
Smo) is known to localize along the entire length of the ciliary
membrane when overexpressed in cells (Rohatgi et al., 2009).
Remarkably, the W-peptide was sufficient to restrict Smo to
the EvC zone when fused to the C terminus of YFP-Smo (Figures
4H–4J and Figure S4F). The FV motif was again critical because
mutation of this motif in the W-peptide abrogated its ability to
target Smo to the EvC zone (Figure 4K). The W-peptide did not
induce ciliary or EvC zone localization when fused to a Smo trun-Developmcation mutant (SmoDC) that was unable to localize to cilia (Fig-
ure S4G). Thus, the W-peptide deleted from Evc2 in patients
with Weyers is not a cilia-targeting signal; rather, it is a portable
sequence that is both necessary and sufficient to mediate the
localization of ciliary membrane proteins to the EvC zone.
The Localization of Evc2 Mutants Predicts Their
Phenotype in Hh Signaling
Our results suggested the intriguing idea that Evc2DW is a domi-
nant-negative protein in Weyers patients because it is dispersed
throughout the ciliary membrane rather than being restricted to
the EvC zone. To investigate whether the ciliary localization of
Evc2DW was necessary for its dominant-negative phenotype,
we generated C-terminally truncated Evc2 proteins modeled
on recessive disease alleles found in EvC patients (Ruiz-Perez
and Goodship, 2009; Valencia et al., 2009). In comparison with
Evc2DW (which lacks the C-terminal 43 aa), Evc2D1157-1220
and Evc2D1133-1220 lack slightly longer fragments spanning
the C-terminal 64 and 88 aa, and Evc2D1157-1176 carries an
internal deletion in this region (Figure 5A). Among these mutants,
only Evc2D1157-1220 blocked Hh signaling (Figure 5A). Analo-
gously to Evc2DW, Evc2D1157-1220 was targeted to cilia but
distributed along the entire ciliary membrane (Figure 5A). In con-
trast, neither Evc2D1133-1220 nor Evc2D1157-1176 strongly
blocked Hh signaling. The former was not targeted to cilia atental Cell 23, 823–835, October 16, 2012 ª2012 Elsevier Inc. 827
Figure 4. The W-Peptide Is a Localization Signal for the EvC Zone
(A) Evc2DW-YFP (green) is localized along the entire length of cilia (red) in Evc2DW cells regardless of Hh signaling (2 hr).
(B) STED image of Evc2DW-YFP distribution at cilia.
(C) Evc2DW-YFP localization relative to various ciliary compartments (compare with Figure 1H).
(D) Mean (± SD) SAG-induced Hh reporter activity in cells transfected with the indicated deletion mutants of Evc2.
(E) Protein sequence of the region between residues 1177 and 1198 of Evc2 that was analyzed by alanine-scanning mutagenesis. For each of the ten mutants
(Evc2A1–A10), the indicated stretch of four aa was mutated to alanines (A). The FV motif, which is critical for suppression of Hh signaling, is circled in red.
(F) Effects of the Evc2 mutants from (E) on Hh signaling induced by SAG (mean ± SD). The red line marks a 50% reduction in reporter activity compared with
WT Evc2.
(G) T-Coffee multiple sequence alignment of the W-peptide in mouse, human, chicken, and fugu Evc2. Boxes encircle positions where Ala mutations produce
(red) or fail to produce (green) a dominant-negative effect (see Figures S4D and S4E). The red line underlines the region subjected to Ala-scanning mutagenesis
in (E). Identical (*), conserved (:) and semiconserved (d) residues are indicated.
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Figure 5. The Targeting of Evc2 to the EvC Zone Is Critical for Its Function
(A) A series of Evc2-YFP deletion mutants (ii) were characterized for their effects on SAG-stimulated Hh reporter activity (mean ± SD) (i) and for their localization in
cilia (iii and iv). The localization of the Evc2 variants (green, anti-YFP) at cilia (red) was consistent across a range of expression levels in transiently transfected cells
(graph in iv is drawn as in Figure 4J).
(B) Ciliary localization of selected Evc2 mutants (green, anti-YFP) described in Figure 4 at cilia (red) of transiently transfected cells (n  20 for each construct).
Scale bars, 2.5 mm.
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(Figure 5A).
To further test the correlation between mislocalization along
the entire ciliary membrane and the dominant-negative pheno-
type, we examined a series of Evc2 mutants with varying effects
on Hh signaling. In each case,mutants restricted to the EvC zone
did not block Hh signaling, whereas those that were dispersed
along the entire cilium were dominant inhibitors of the pathway
(Figures 4F and 5B). Ala mutations (Evc2A4 and Evc2A5) over-
lapping the FV motif of the W-peptide that blocked Hh signaling
also mislocalized Evc2 throughout the ciliary membrane (Fig-
ure 5B). We propose that this FV motif is required for a protein
interaction that restricts Evc2 to the EvC zone and facilitates
Smo signaling. More generally, the above correlations provide
functional evidence that both targeting to the cilium and restric-
tion to the EvC zone are critical for the proper function of Evc2 in(H) YFP-SmoW was constructed by transferring the W-peptide (blue) from Evc2
(I) Localization of YFP-Smo and YFP-SmoW (green) at cilia (red) after transient ex
EvC zone.
(J) Localization of YFP-Smo and YFP-SmoW at the EvC zone (orange) or the whol
proteins after transient transfection. Whole-cell YFP fluorescence is plotted for eac
construct (n = 30).
(K) A mutant W-peptide carrying the A5 mutation that overlaps the FV motif (YFP
Scale bars: 2.5 mm and 0.5 mm in (B).
See also Figure S4.
DevelopmHh signaling. It is important to emphasize that prior to the work
presented here, the only evidence that Evc2 functioned in cilia
(or that EvC and Weyers are indeed ciliopathies) was the obser-
vation that it was localized in cilia (Blair et al., 2011).
Evc2 Associates with Smo in Response to Hh Signaling
The requirement for Evc2 at a specific step in Hh signaling led us
to consider whether it associated with Hh pathway components
that function at this step. We tested this association in Evc2-YFP
cells, where both the Hh components and Evc2-YFP are ex-
pressed at endogenous levels (Figure 1D). To stabilize protein
interactions during the detergent-solubilization step required
to extract Evc2 from membranes, we treated cells with the
membrane-permeable, reversible crosslinker dithiobis(succini-
midyl propionate) (DSP). DSP was added to intact cells and
then inactivated prior to cell lysis to circumvent artifactualto the C terminus of YFP-Smo. Yellow star: YFP tag.
pression in NIH/3T3 cells. Figure S4F shows that YFP-SmoW is localized to the
e cilium (blue) in individual cells (circles) expressing varying amounts of the two
h cell; the black barmarks themean fluorescence (or expression level) for each
-SmoWA5) (E) and inhibits Hh signaling (F) cannot target Smo to the EvC zone.
ental Cell 23, 823–835, October 16, 2012 ª2012 Elsevier Inc. 829
Figure 6. Hh Signaling Promotes the Association of Smo with Evc2
(A) Immunoblotting was used to assess the presence of Gli2, Evc, Smo, SuFu, and PKA-Ca in anti-YFP immunoprecipitates from Evc2-YFP cells left untreated
(control) or treated with SAG (2 hr). Input and flow-through (FT) samples show the amount of each protein in the whole extract before and after the IP, respectively.
In this panel and in (B)–(D), IP was performed after whole-cell crosslinking (DSP, 0.1 mM).
(B) Immunoblots showing the amount of endogenous Smo that coprecipitated with Evc2-YFP from cells left untreated or treated with SAG or Shh for 2 hr.
(C) Immunoblots showing the amounts of Gli2, Smo, SuFu, and PKA-Ca that coprecipitated with Evc-YFP from SAG-treated (2 hr) cells stably expressing the
protein.
(D) Immunoblots showing the amount of Smo that coprecipitated with Evc2-YFP or Evc2DW-YFP from SAG-treated (2 hr) stable cell lines. A control IP was per-
formedwithcells lacking aYFP-taggedEvc2bait protein (vector control). Blue arrowsdenote thehighermolecularweight fractionofSmo that associatedwithEvc2.
(E) Immunoblots showing the amount of Evc2-YFP and Evc2DW-YFP that coprecipitated with endogenous Evc fromSAG-treated (2 hr) cells on anti-Evc beads or
control IgG beads.
(F) Immunoblots showing amounts of endogenous Evc2 that coprecipitatedwith Evc2-YFP or Evc2DW-YFP using anti-YFP beads or control IgG beads from cells
treated with SAG (2 hr).
(G) Localization of endogenous Evc (red) at cilia (white) in Evc2 and Evc2DW cells (anti-YFP, green).
(H) An Evc2 antibody directed exclusively against the W-peptide (anti-Evc2W; Figure S5A) was used to assess the ciliary localization of Evc2 (red) in Evc2-YFP
and Evc2DW-YFP cells (anti-YFP, green).
(I) Summary of the interactions between Evc2, Evc2DW, Evc, and Smo. Evc2 can self-associate, but Evc2DW cannot associate with Evc2. Scale bars: 2.5 mm.
See also Figure S5.
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Evc2-YFP showed an interaction with Evc and Smo, but not
with Gli2, SuFu, or PKA (Figure 6A). Although the Evc2–Evc inter-
action was constitutive, the interaction between Evc2-YFP and830 Developmental Cell 23, 823–835, October 16, 2012 ª2012 ElsevSmo was only detectable when Hh signaling was activated by
Shh or SAG (Figures 6A and 6B).
To demonstrate the specificity of the Smo-Evc2 interaction,
we used a panel of different antibodies (summarized inier Inc.
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A Smo-Evc2 Complex Transduces the Hedgehog SignalFigure S5A) to assay the interaction between YFP-Smo and Evc2
in extracts from smo/;YFP-Smo MEFs (Rohatgi et al., 2009)
without the use of a protein crosslinker. The interaction between
Evc2 and YFP-Smo could be readily detected when endogenous
Evc2 was isolated using an anti-Evc2 antibody or, in reciprocal
immunoprecipitations (IPs), when YFP-Smo was isolated using
three different antibodies (Figures S5B–S5D). Crosslinking with
DSP substantially stabilized the interaction between Evc2 and
YFP-Smo in a dose-dependent fashion (Figure S5E). Taken
together, these IP experiments using five antibodies against
independent epitopes in two different cell lines confirmed the
Hh-stimulated interaction between Smo and Evc2. Consistent
with the observation that Evc and Evc2 form a complex (Blair
et al., 2011), we also detected an interaction between Smo
and Evc (Figure 6C).
Having established these interaction assays, we sought to
understand the molecular basis for the dominant-negative
activity of Evc2DW. We started by testing whether Evc2DW
could still bind to Smo and Evc. Compared with Evc2-YFP,
Evc2DW-YFP showed a substantially stronger interaction with
Smo (Figure 6D and Figure S5F). Thus, the interaction of Smo
and Evc2 does not require the W-peptide. Moreover, the
W-peptide was not required for the binding of Evc2 to Evc (Fig-
ure 6E). Next, we tested the ability of Evc2-YFP and Evc2DW-
YFP to form complexes with endogenous Evc2. Evc2-YFP
was able to bind endogenous Evc2, suggesting that Evc2
can form homo-oligomers in cells (Figure 6F). This ability to
multimerize was compromised by loss of the W-peptide,
since Evc2DW-YFP failed to bind endogenous Evc2 (Fig-
ure 6F). Consistent with these biochemical data, we found
that Evc2DW expression could displace endogenous Evc (Fig-
ure 6G), but not endogenous Evc2 (Figure 6H), from the EvC
zone and cause it to spread along the entire length of the cilium.
Taken together, we propose that the critical biochemical defect
in Evc2DW is its inability to multimerize with endogenous Evc2
(Figure 6I).
Spatial Restriction of the Smo-Evc2 Interaction to
Primary Cilia
During our interaction analyses, we found that Evc2 selectively
bound the fraction of total Smo that demonstrated slower
mobility on SDS-PAGE (Figure 6D and Figure S5F), consistent
with a post-Golgi glycosylation pattern (Figure S4C). Indeed,
Smo that coprecipitated with Evc2 and Evc2DW was resistant
to digestion with EndoH and sensitive to digestion with PNGaseF
(Figure S6A), formally showing that it carried the glycosylation
hallmark of transit through the Golgi.
Thus, the Smo-Evc2 interaction was both induced by Hh
signaling and spatially restricted to a post-Golgi compartment.
The primary ciliumwas themost likely location for this interaction
because Evc2 and Smo were colocalized in the EvC zone after
Hh pathway activation (by both conventional and superresolu-
tion microscopy), with little colocalization throughout the rest
of the cell (Figure 7A; Figures S6B and S6C). Consistent with
our IP data, Evc2DW, which was distributed throughout the
cilium, showed a greater degree of overlap with Smo in the cilium
(Figure 7A). An in situ proximity ligation assay (Duolink) demon-
strated that Evc2 and Smo were located within 40 nm of each
other at the cilium (Figures S6D–S6F).DevelopmThree independent experiments suggested that cilia were
required for the interaction of Smo and Evc2. First, growth of
cells in the presence of high serum, which is known to block cilio-
genesis (Tucker et al., 1979), substantially inhibited the interac-
tion between Smo and Evc2 (Figure 7B). Similar results were
obtained with cells that stably expressed a dominant-negative
fragment of the anterograde motor Kif3a (dnKif3a), which led to
the loss of cilia in a majority of cells (Figure 7C; Figures S7A
and S7B). Finally, the interaction between Smo and Evc2
was abrogated by independent mutations in Smo and in Evc2
that prevented the ciliary localization of either protein (Figures
S7C–S7F).
Smo can adopt either an active or an inactive conformation in
cilia (Rohatgi et al., 2009). Both SAG, a Smo agonist, and cyclop-
amine, a Smo antagonist, can induce the accumulation of Smo in
cilia. However, the association between Smo and Evc2 was only
detected in cells treated with SAG (Figure 7D; Figures S7G and
S7H). Thus, the Smo-Evc2 interaction appears to be sensitive
to both the integrity of the primary cilia and the active conforma-
tion of Smo.
Within the cilium, the EvC zone is the most likely place for an
association between Smo and Evc2. However, because Smo
is often found throughout the ciliary membrane, this raises an
important question: precisely where in the cilium is Smo activity
required to transduce the Hh signal? We tested the signaling
activity of a Smo protein that was tethered to the EvC zone by
fusion of the W-peptide (YFP-SmoW; Figure 4H). If Smo activity
is required at the tips of cilia, as proposed by some models
(Goetz et al., 2009), YFP-SmoW should show less signaling
activity compared with theWT YFP-Smo protein, which localizes
throughout the cilium. Instead, both with and without SAG, YFP-
SmoWwas2-fold more active than YFP-Smo, even though the
former was present in cilia at 2.6-fold lower levels (Figures 7E
and 7F). Notably, SmoW is not a fully activated protein, because
its activity is dwarfed by that of the constitutively active SmoM2
mutant and its activity can be suppressed by cyclopamine (Fig-
ure 7E and Figure S7I). Taken together, these results are con-
sistent with the notion that Smo signaling at the cilium is
compartmentalized in the EvC zone and facilitated by associa-
tion with Evc2.
DISCUSSION
The primary cilium has been called a ‘‘Hedgehog signal
transduction machine’’ (Goetz et al., 2009). The input into this
machine is the accumulation of Smo in the ciliary membrane,
and the output is activated Gli transcription factors that can
transit to the nucleus and initiate the Hh transcriptional program.
Our discovery of a Smo-Evc2 signaling complex sheds light on
the signal transduction step between Smo and PKA/SuFu, a
step that is poorly understood in mammalian Hh signaling. The
association of Smo with Evc2 in a distinct compartment in pri-
mary cilia, the EvC zone, is required for the two outputs of
Smo, the inhibition of Gli3 repressor formation and the induction
of Gli2 and Gli3 activator formation (Figure 7G).
The EvC zone may represent an important signaling compart-
ment in primary cilia, with implications for understanding ciliopa-
thies and skeletal dysplasia syndromes. Interestingly, the EvC
zone is located immediately adjacent to the TZ, which forms aental Cell 23, 823–835, October 16, 2012 ª2012 Elsevier Inc. 831
Figure 7. Association of Evc2 and Smo at Primary Cilia
(A) Colocalization of Smo (red) and Evc2-YFP or Evc2DW-YFP (anti-YFP, green) at cilia (white) of stable cell lines left untreated or treated with SAG (4 hr). Scale
bar: 2.5 mm.
(B) Immunoblots showing the amount of endogenous Smo that coprecipitated with Evc2-YFP and Evc2DW-YFP on anti-YFP beads from cells grown in high
serum or low serum (to efficiently induce ciliation) and exposed to SAG (2 hr).
(C) Association of endogenous Smo with Evc2-YFP in cells expressing dnKif3a (to ablate cilia) or cells expressing an empty control vector. In dnKif3a or control
cells, Smo-Evc2 association (left axis), expressed as the ratio of Smo pulled down per unit of Evc2, is compared with the percentage of cells that form cilia (right
axis, mean ± SD). Primary data are shown in Figures S7A and S7B.
(D) Association between Smo and Evc2-YFP in cells left untreated or treated with SAG or cyclopamine (Cycl, 5 mM) for 2 hr. In control-, cyclopamine-, or SAG-
treated cells, Smo-Evc2 association (left axis) is compared with the intensity of Smo fluorescence (mean ± 95% CI) at cilia (right axis). Primary data are shown in
Figures S7G and S7H.
(E) Mean (± SD) Hh reporter activity in cells transiently expressing YFP-Smo, YFP-SmoW, or YFP-SmoWA5 and left untreated or treated with SAG. In each case,
data are shown relative to WT YFP-Smo.
(F) Bar graph showing the mean (± 95% CI; n = 19) fluorescence of YFP-Smo or YFP-SmoW at cilia.
(G–I) Models for the function of Evc2 in Hh signaling. In all three models, the localization of WT Evc2 and Evc is restricted to the EvC zone, located just distal to the
transition zone in cilia. (G) In the absence of Shh (left), PKA channels Gli proteins toward the formation of transcriptional repressors (Gli3R) and away from the
formation of Gli activators (GliA). Shh (right) promotes the association of Smowith Evc/Evc2 in the EvC zone, leading to an active Hh signaling complex (HSC) that
Developmental Cell
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A Smo-Evc2 Complex Transduces the Hedgehog Signalgate for ciliary protein entry and is also populated by several cili-
opathy proteins (Czarnecki and Shah, 2012). Crosstalk between
these adjacent zones would provide a mechanism by which
signaling events at the EvC zone could impact trafficking deci-
sions made at the TZ. Targeting of Evc2 to the EvC zone is
accomplished by two hierarchical but separable steps: (1) traf-
ficking to the cilium and (2) restriction of Evc2 distribution to
the Evc zone. This two-step mechanism for Evc2 localization
provides a parsimonious explanation for the opposite modes
of inheritance seen in recessive EvC and dominant Weyers
disease. The mutant Evc2 proteins found in EvC are nonfunc-
tional because they fail to localize to cilia (Figure 7H), whereas
the mutants in Weyers interfere with Hh signaling because they
are mislocalized throughout the ciliary membrane (Figure 7I).
Although Smo is absolutely required for Hh signaling in all
tissues, Evc2 and Evc likely play more tissue-specific roles. In
humans, loss-of-function mutations in EVC or EVC2 lead to clear
Hh phenotypes in the skeleton, heart, and orofacial tissues, but
few phenotypes in other Hh-patterned tissues, such as the
nervous system and the gut (Ruiz-Perez and Goodship, 2009).
At least in humans, this tissue specificity cannot be explained
by a redundancy between EVC and EVC2, because those rare
patients who carry a deletion that eliminates both genes do not
show more severe phenotypes (Temtamy et al., 2008). We favor
the model in which a different protein or mechanism appropri-
ates the function of Evc2 in tissues such as the nervous system,
because, at least in the mouse, neither EVC nor EVC2 is ex-
pressed there during development (Takeda et al., 2002; Ruiz-
Perez et al., 2007). Given the importance of Smo as a drug target
and the importance of Hh signaling in diverse tissues, this obser-
vation suggests that wemay be able to interrupt Smo signaling in
a tissue-selective manner by targeting accessory proteins, such
as Evc2, rather than Smo itself.
EXPERIMENTAL PROCEDURES
Constructs and Reagents
Mouse full-length Evc2 (NM_145920.3) and Evc2DW (aa 1–1176) were tagged
with either a single FLAG tag or a dual YFP-FLAG tag at the C terminus. Mouse
full-length Evc (NM_021292.2) was tagged with a dual YFP-FLAG tag at the
C terminus. Mutations were introduced by inverse PCR, the QuikChange
method (Agilent), or gene synthesis (DNA2.0). We obtained SAG from Enzo
Life Sciences, 20-OHC from Steraloids, cyclopamine from Toronto Research
Chemicals, cycloheximide and puromycin from Sigma, PNGaseF and EndoH
from New England Biolabs, DSP from Thermo Scientific, and n-dodecyl-b-D-
maltopyranoside and cholesteryl-hemisuccinate from Affymetrix.
Cell Lines
NIH/3T3, C3H10T1/2, and IMCD3 cells were obtained from ATCC. The stable
cell lines expressing tagged Evc, Evc2, and Evc2 mutants were produced by
site-specific recombination into a single site in the genome of 3T3 cells using
the Flp-In system (Invitrogen). The Evc2-YFP;dnKif3a and Evc2-YFP;vector
cell lines were generated by infecting Evc2-YFP cells with a retrovirus carrying
dominant-negative Kif3a cloned into pRetroX-pTuner or a retrovirus carryingrelieves the negative effect of PKA on the Gli proteins. TheGli-SuFu complex trans
nuclear translocation of Glis, and the transcription of target genes. Only the popul
EvC syndrome, mutant Evc2 proteins fail to localize in cilia, preventing the formati
protein is not confined to the EvC zone, thus sequestering Smo and Evc in inactiv
Smo is outlined in green and inactive Smo is outlined in red.
See also Figures S6 and S7.
Developmthe empty pRetroX-pTuner vector. Stable transductants were selected in
2 mg/ml puromycin.
Antibodies
Polyclonal antibodies against the intracellular domain of mouse Evc2 (aa 232–
1220) or Evc (aa 461–1005) were generated in rabbits (Cocalico Biologicals)
and affinity purified prior to use (Figure S5A). Anti-Evc2W, the antibody that
selectively recognizes full-length Evc2 but not Evc2DW, was generated by
affinity purification of the antisera against the W-peptide alone. Commercially
available antibodies or polyclonal antisera that were previously described are
listed in Supplemental Experimental Procedures.
Assays for Hedgehog Pathway Activation
Fibroblasts were grown to confluence in medium (high-glucose Dulbecco’s
modified Eagle’s medium (DMEM), 0.05 mg/ml penicillin, 0.05 mg/ml strepto-
mycin, 2 mM GlutaMAX, 1 mM sodium pyruvate, 0.1 mM MEM nonessential
amino acid supplement) containing 10% fetal bovine serum (FBS; HyClone)
and then switched to medium containing 0.5% FBS with pathway agonists
for 24 hr (unless indicated otherwise). In all cases, SAG was used at 100 nM
and Shh conditioned medium at a 1/4 dilution. Whole-cell lysates were
prepared in 50mM Tris pH 7.4, 150mMNaCl, 2% [v/v] NP-40, 0.25% [w/v] de-
oxycholate, 1 mM dithiothreitol (DTT), and 1X Sigma Fast EDTA-free protease
inhibitor cocktail. For Hedgehog reporter assays, cells were transiently trans-
fected using Fugene 6 (NIH/3T3 cells) with a mixture (4:1) of a firefly luciferase
reporter driven by a Gli-responsive promoter and a constitutive Renilla lucif-
erase reporter (Sasaki et al., 1997) together with the construct of interest. Cells
were grown to confluence and switched to medium containing 0.5% FBS with
pathway agonists or antagonists for 24 hr. In the graphs, each data point repre-
sents the mean of triplicate wells, with error bars representing the standard
deviation (SD).
Alkaline Phosphatase Assay
For the alkaline phosphatase expression assay (Hyman et al., 2009), C3H10T1/
2 cells were transfected with an Evc2 or NT control siRNA, grown to conflu-
ency, and treated with SAG (100 nM) for 36 hr in 0.5% FBS containing
DMEM. After lysis (100 mM Tris pH 9.4, 250 mM NaCl, 25 mM MgCl2, 1%
[v/v] Triton X-100), alkaline phosphatase activity was measured using the
CDP-Star Chemiluminescence reagent (Perkin Elmer).
IP and DSP Crosslinking
Whole-cell extracts or membrane extracts were incubated with antibodies
covalently coupled to Protein A-coated magnetic beads or GFP-binding pro-
tein (GBP) covalently coupled to M270 carboxylic acid beads (both Dynal).
To crosslink proteins prior to IP, cells were washed with D-PBS (PBS, 1 mM
CaCl2, 1 mM MgCl2) and incubated with the crosslinker DSP for 30 min on
ice. Following DSP inactivation (100 mM Tris pH 7.4, 30 min), cells were har-
vested and lysed in a DTT-free buffer (50 mM Tris pH 7.4, 150 mM NaCl, 2%
[v/v] NP-40, 0.25% [w/v] deoxycholate, 10 mg/ml LPC, and 1X Sigma Fast
EDTA-free protease inhibitor cocktail). After this extract was incubated with
antibody-coupled beads, proteins were eluted and crosslinks were reversed
with a reducing SDS sample buffer containing 50 mM tris-2-carboxyethyl-
phosphine hydrochloride (TCEP).
siRNA and Endoribonuclease-Prepared siRNA Transfections
siRNA and endoribonuclease-prepared siRNA (esiRNA) reagents for Evc2
(siRNA: SASI_Mm_01_00106977; esiRNA: EMU014101), Smo (siRNA: SASI_
Mm_02_00346929, esiRNA: EMU047471), and nontargeting controls were ob-
tained from Sigma. NIH/3T3 cells were reverse transfected with 38 nM of
siRNA or esiRNA using Lipofectamine RNAiMax (Invitrogen) according to the
manufacturer’s instructions.locates to the tip of the cilium, ultimately leading to the dissociation of SuFu, the
ation of Smo at the EvC zone participates in an active HSC. (H) In the recessive
on of an active HSC. (I) In the dominant Weyers syndrome, the mutant Evc2DW
e complexes and preventing assembly of a functional HSC. In all panels, active
ental Cell 23, 823–835, October 16, 2012 ª2012 Elsevier Inc. 833
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Cultured cells were fixed in 4% [w/v] paraformaldehyde (PFA) in PBS for
10 min at room temperature (RT) and washed in PBS (3 3 5 min). Fixed
cells were incubated with blocking buffer (1% [v/v] normal donkey serum,
10 mg/ml [w/v] bovine serum albumin, 0.1% [v/v] Triton X-100 in PBS) for
30 min at RT. Primary antibodies were diluted in blocking buffer and used
to stain cells for 1 hr at RT or overnight at 4C. After washing (3 3 5 min in
PBS containing 0.1% [v/v] Triton X-100) was completed, secondary anti-
bodies were added in blocking buffer and incubated for 1 hr at RT. Stained
cells were washed as above and mounted with DAPI containing anti-fade
medium (Mowiol).
Microscopy was performed on an inverted Leica SP2 or SP5 laser scanning
confocal microscope or an inverted Leica DMIRE2 epifluorescence micro-
scope. Epifluorescence images, taken as z-stacks, were deconvolved (Auto-
Quant). In all figures, cilia are oriented with their base to the left and their tip
to the right. Although markers of the cilia base are only shown in selected
images, ciliary orientation was explicitly established using a basal bodymarker
(gamma tubulin) in all cases. For superresolution microscopy, cells were
seeded on #1.5H coverslips (Zeiss) and processed for IF using secondary anti-
bodies (Atto425 and Alexa488) compatible with two-color stimulated emission
depletion (STED). Images were taken as z-stacks on a Leica TCS STED CW
system and deconvolved using the built-in Leica STED-2D-deconvolution
software.
Data Analysis
Films were scanned with an Epson Perfection V700 photoscanner as
grayscale TIFF files (600 dpi). Quantitative analysis of band intensities
was performed with ImageJ, and the data were transferred to GraphPad
Prism for analysis. To calculate the fraction of GliFL in the nucleus or
cytoplasm, we calculated the ratios N/(N+C) and C/(N+C), where N and C
are the intensities of the GliFL band in nuclear and cytoplasmic fractions,
respectively.
For the quantitative analysis of fluorescence intensities, all images were
obtained with identical gain, offset, and laser power settings. To compare
the mean Smo, Gli2, Gli3, and SuFu fluorescence levels at the primary cilium,
we used a one-way ANOVA with a Tukey posttest to assess statistical signif-
icance. In addition, a Kruskal-Wallis test was used to compare themedian fluo-
rescence data to avoid assumptions about the normality of the underlying
distribution. There was no difference between the two tests.
For the single-cell analysis of the ciliary localization of YFP-tagged Smo or
Evc2mutants (Figures 4E, 5B, and 5D), wemeasured whole-cell YFP immuno-
fluorescence intensity (taken as a measure of protein expression) by outlining
the entire cell and using the integrated density function of ImageJ. In the same
cell, the localization of Smo or Evc2 was classified as absent, present in the
EvC zone, or present throughout the whole cilium. The mean fluorescence
derived from measurements of multiple cells reflects the average protein
expression in the cell population.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2012.07.004.
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